BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2015 Annual Data Report: Liver. Am J Transplant. 2017;17 Suppl 1:174-251. [PMID: 28052604 DOI: 10.1111/ajt.14126] [Cited by in Crossref: 215] [Cited by in F6Publishing: 184] [Article Influence: 43.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang S, Sun C, Hou Y, Tang Y, Zhu Z, Zhang Z, Zhang Y, Wang L, Zhao Q, Chen MG, Guo Z, Wang D, Ju W, Zhou Q, Wu L, He X. A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Sci Rep 2018;8:7630. [PMID: 29769552 DOI: 10.1038/s41598-018-25658-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
2 Wang W, Liu Z, Qian J, Xu J, Que S, Zhuang L, Geng L, Zhou L, Zheng S. Systematic Assessment of Safety Threshold for Donor Age in Cadaveric Liver Transplantation. Front Med (Lausanne) 2021;8:596552. [PMID: 33748155 DOI: 10.3389/fmed.2021.596552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Feng S. Living donor liver transplantation in high Model for End-Stage Liver Disease score patients. Liver Transpl 2017;23:S9-S21. [PMID: 28719072 DOI: 10.1002/lt.24819] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
4 Chen Q, You Y, Zhang Y, Zhang H, Bai L. Hepatocyte growth factor mediates a novel form of hepatic stem/progenitor cell-induced tolerance in a rat xenogeneic liver rejection model. Int Immunopharmacol 2021;90:107180. [PMID: 33221167 DOI: 10.1016/j.intimp.2020.107180] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Alsahhar JS, Mehta A, Lepe R. Con: Liver Transplantation Should Not Be Performed in Patients With Acute Alcoholic Hepatitis. Clin Liver Dis (Hoboken) 2019;13:144-7. [PMID: 31236263 DOI: 10.1002/cld.779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Doycheva I, Issa D, Watt KD, Lopez R, Rifai G, Alkhouri N. Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States. Journal of Clinical Gastroenterology 2018;52:339-46. [DOI: 10.1097/mcg.0000000000000925] [Cited by in Crossref: 47] [Cited by in F6Publishing: 25] [Article Influence: 11.8] [Reference Citation Analysis]
7 Wray CL. Advances in the Anesthetic Management of Solid Organ Transplantation. Advances in Anesthesia 2017;35:95-117. [DOI: 10.1016/j.aan.2017.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Azab M, Shah S, Liu X, Ukken J, Froehlich M, Shafi A, Al Dawoodi T, Liu C, Shin HP, Yoo JW. Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations. J Hepatol 2018;68:626-7. [PMID: 29079290 DOI: 10.1016/j.jhep.2017.09.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Chen Z, Lin X, Chen C, Chen Y, Zhao Q, Wu L, Wang D, Ma Y, Ju W, Chen M, He X. Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation. Ann Transl Med. 2020;8:1067. [PMID: 33145286 DOI: 10.21037/atm-20-2751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Russo MW. The Care of the Postliver Transplant Patient. J Clin Gastroenterol 2017;51:683-92. [PMID: 28796003 DOI: 10.1097/MCG.0000000000000886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
11 Ramos-Gonzalez G, Elisofon S, Dee EC, Staffa SJ, Medford S, Lillehei C, Kim HB. Predictors of Need for Liver Transplantation in Children Undergoing Hepatoportoenterostomy for Biliary Atresia.J Pediatr Surg. 2019;54:1127-1131. [PMID: 30879751 DOI: 10.1016/j.jpedsurg.2019.02.051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
12 Pimentel RRS, Garcia IM, Galdino MJQ, Pissinati PSC, Rossaneis MA, Gvozd Costa R, Silva LGC, Haddad MCFL. Liver Donations and Transplants in the State of Paraná, Brazil. Transplant Proc 2019;51:632-8. [PMID: 30979445 DOI: 10.1016/j.transproceed.2018.12.031] [Reference Citation Analysis]
13 Bababekov YJ, Hung YC, Rickert CG, Njoku FC, Cao B, Adler JT, Brega AG, Pomposelli JJ, Chang DC, Yeh H. Health Literacy Burden Is Associated With Access to Liver Transplantation. Transplantation 2019;103:522-8. [PMID: 30431496 DOI: 10.1097/TP.0000000000002536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Okajima H, Uemoto S. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. J Cachexia Sarcopenia Muscle 2018;9:246-54. [PMID: 29453829 DOI: 10.1002/jcsm.12276] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
15 Baker TB. Liver Paired Exchange: Ready for Prime Time in North America? Liver Transpl 2019;25:1609-10. [DOI: 10.1002/lt.25639] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pan ET, Yoeli D, Galvan NTN, Kueht ML, Cotton RT, O'Mahony CA, Goss JA, Rana A. Cold ischemia time is an important risk factor for post-liver transplant prolonged length of stay. Liver Transpl 2018;24:762-8. [PMID: 29476693 DOI: 10.1002/lt.25040] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
17 Abdulrahim N, Anderson L, Kotla S, Liu H, Ariyamuthu VK, Ghanta M, Macconmara M, Tujios SR, Mufti A, Mohan S, Marrero JA, Vagefi PA, Tanriover B. Lack of Benefit and Potential Harm of Induction Therapy in Simultaneous Liver-Kidney Transplants. Liver Transpl 2019;25:411-24. [DOI: 10.1002/lt.25390] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
18 Du C, Feng Y, Qiu D, Xu Y, Pang M, Cai N, Xiang AP, Zhang Q. Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails. Stem Cell Res Ther 2018;9:58. [PMID: 29523187 DOI: 10.1186/s13287-018-0794-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
19 Berumen J, Hemming A. Liver transplantation for hepatocellular carcinoma. Abdom Radiol 2018;43:185-92. [DOI: 10.1007/s00261-017-1217-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
20 Zhang XM, Fan H, Wu Q, Zhang XX, Lang R, He Q. In-hospital mortality of liver transplantation and risk factors: a single-center experience. Ann Transl Med 2021;9:369. [PMID: 33842590 DOI: 10.21037/atm-20-5618] [Reference Citation Analysis]
21 Agopian VG. Liver transplantation with donation after cardiac death donors as a strategy for recipients with model for end-stage liver disease score >15: Has the die been cast? Liver Transpl 2017;23:579-80. [PMID: 28296066 DOI: 10.1002/lt.24756] [Reference Citation Analysis]
22 Cillo U, Bechstein WO, Berlakovich G, Dutkowski P, Lehner F, Nadalin S, Saliba F, Schlitt HJ, Pratschke J. Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression. Transplantation Reviews 2018;32:142-50. [DOI: 10.1016/j.trre.2018.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Lee IS, Park SH, Choi SJ, Shim Y, Ahn SJ, Kim KW, Kim KK, Jeong YM, Choe YH. Diagnostic Performance of Multidetector Computerized Tomography in the Detection of Abdominal Complications Early and Late After Liver Transplantation: A 10-Year Experience. Transplant Proc 2018;50:3673-80. [PMID: 30577254 DOI: 10.1016/j.transproceed.2018.09.016] [Reference Citation Analysis]
24 Mathurin P, Lucey MR. Alcohol, liver disease, and transplantation: shifting attitudes and new understanding leads to changes in practice. Current Opinion in Organ Transplantation 2018;23:175-9. [DOI: 10.1097/mot.0000000000000517] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
25 Grąt M, Krawczyk M, Wronka KM, Stypułkowski J, Lewandowski Z, Wasilewicz M, Krawczyk P, Grąt K, Patkowski W, Zieniewicz K. Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation. Sci Rep 2018;8:8935. [PMID: 29895820 DOI: 10.1038/s41598-018-27319-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
26 Kozlitina J. Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis. Gastroenterol Clin North Am 2020;49:25-44. [PMID: 32033763 DOI: 10.1016/j.gtc.2019.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
27 Noureddin M, Vipani A, Bresee C, Todo T, Kim IK, Alkhouri N, Setiawan VW, Tran T, Ayoub WS, Lu SC, Klein AS, Sundaram V, Nissen NN. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances. Am J Gastroenterol. 2018;113:1649-1659. [PMID: 29880964 DOI: 10.1038/s41395-018-0088-6] [Cited by in Crossref: 181] [Cited by in F6Publishing: 167] [Article Influence: 45.3] [Reference Citation Analysis]
28 Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, Im GY, Therapondos G, Han H, Victor DW, Fix OK, Dinges L, Dronamraju D, Hsu C, Voigt MD, Rinella ME, Maddur H, Eswaran S, Hause J, Foley D, Ghobrial RM, Dodge JL, Li Z, Terrault NA. Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis. Gastroenterology 2018;155:422-430.e1. [PMID: 29655837 DOI: 10.1053/j.gastro.2018.04.009] [Cited by in Crossref: 126] [Cited by in F6Publishing: 100] [Article Influence: 31.5] [Reference Citation Analysis]
29 Burra P, Shalaby S, Zanetto A. Long-term care of transplant recipients: De novo neoplasms after liver transplantation. Curr Opin Organ Transplant. 2018;23:187-195. [PMID: 29324517 DOI: 10.1097/mot.0000000000000499] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
30 Ore A, Akinloye OA. Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease. Medicina (Kaunas) 2019;55:E26. [PMID: 30682878 DOI: 10.3390/medicina55020026] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 15.0] [Reference Citation Analysis]
31 Shah ND, Ventura-Cots M, Abraldes JG, Alboraie M, Alfadhli A, Argemi J, Badia-Aranda E, Arús-Soler E, Barritt AS 4th, Bessone F, Biryukova M, Carrilho FJ, Fernández MC, Dorta Guiridi Z, El Kassas M, Eng-Kiong T, Queiroz Farias A, George J, Gui W, Thurairajah PH, Hsiang JC, Husić-Selimovic A, Isakov V, Karoney M, Kim W, Kluwe J, Kochhar R, Dhaka N, Costa PM, Nabeshima Pharm MA, Ono SK, Reis D, Rodil A, Domech CR, Sáez-Royuela F, Scheurich C, Siow W, Sivac-Burina N, Dos Santos Traquino ES, Some F, Spreckic S, Tan S, Vorobioff J, Wandera A, Wu P, Yacoub M, Yang L, Yu Y, Zahiragic N, Zhang C, Cortez-Pinto H, Bataller R. Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide. Clin Gastroenterol Hepatol 2019;17:2320-2329.e12. [PMID: 30708110 DOI: 10.1016/j.cgh.2019.01.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
32 Carbonneau M, Davyduke T, Spiers J, Brisebois A, Ismond K, Tandon P. Patient Views on Advance Care Planning in Cirrhosis: A Qualitative Analysis. Can J Gastroenterol Hepatol 2018;2018:4040518. [PMID: 30079330 DOI: 10.1155/2018/4040518] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
33 Lee BP, Samur S, Dalgic OO, Bethea ED, Lucey MR, Weinberg E, Hsu C, Rinella ME, Im GY, Fix OK, Therapondos G, Han H, Victor DW, Voigt MD, Eswaran S, Terrault NA, Chhatwal J. Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis. Gastroenterology 2019;157:472-480.e5. [PMID: 30998988 DOI: 10.1053/j.gastro.2019.04.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
34 Saab S, Kardashian A, Saggi S, Choi G, Agopian V, Tong MJ. Use of hepatitis C-positive grafts in hepatitis C-negative liver transplant recipients is cost effective. Clin Transplant 2018;32:e13383. [PMID: 30129981 DOI: 10.1111/ctr.13383] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
35 Cuenca AG, Kim HB, Vakili K. Pediatric liver transplantation. Semin Pediatr Surg. 2017;26:217-223. [PMID: 28964477 DOI: 10.1053/j.sempedsurg.2017.07.014] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
36 Weissenbacher A, Vrakas G, Nasralla D, Ceresa CDL. The future of organ perfusion and re-conditioning.Transpl Int. 2019;32:586-597. [PMID: 30980772 DOI: 10.1111/tri.13441] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
37 Wray CL. Liver Transplantation in Patients With Cardiac Disease. Semin Cardiothorac Vasc Anesth 2018;22:111-21. [PMID: 29025297 DOI: 10.1177/1089253217736050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
38 Zerillo J, Smith NK, Sakai T. Noteworthy Literature published in 2017 for Abdominal Organ Transplantation. Semin Cardiothorac Vasc Anesth 2018;22:67-80. [PMID: 29400258 DOI: 10.1177/1089253217753399] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Kato H, Duarte S, Miller MG, Busuttil RW, Coito AJ. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice. Liver Transpl 2019;25:288-301. [PMID: 30358115 DOI: 10.1002/lt.25365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Núñez KG, Frank A, Gonzalez-Rosario J, Galliano G, Bridle K, Crawford D, Seal J, Abbruscato F, Vashistha H, Thevenot PT, Cohen AJ. Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury. PLoS One 2019;14:e0216242. [PMID: 31034519 DOI: 10.1371/journal.pone.0216242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Mehta N, Dodge JL, Grab JD, Yao FY. National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time. Hepatology 2020;71:943-54. [PMID: 31344273 DOI: 10.1002/hep.30879] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 13.7] [Reference Citation Analysis]
42 Zhang T, Barrett S, Cotton R, Galvan NTN, O'Mahony C, Moore Vierling J, Goss JA, Rana A. Pediatric length-of-stay index following liver transplantation. Pediatr Transplant 2020;24:e13779. [PMID: 32720748 DOI: 10.1111/petr.13779] [Reference Citation Analysis]
43 Amubieya O, Ramsey A, DerHovanessian A, Fishbein GA, Lynch JP 3rd, Belperio JA, Weigt SS. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies. Semin Respir Crit Care Med 2021;42:392-410. [PMID: 34030202 DOI: 10.1055/s-0041-1729175] [Reference Citation Analysis]
44 Barman PM, King LY, Berg CL, Parish A, Niedzwiecki D, Barbas AS, McElroy L, Patel YA. Need for Pretransplant Midodrine Does Not Negatively Impact Simultaneous Liver-kidney Transplant Outcomes. Transplant Direct 2021;7:e640. [PMID: 33344762 DOI: 10.1097/TXD.0000000000001071] [Reference Citation Analysis]
45 Rawal N, Yazigi N. Pediatric Liver Transplantation. Pediatr Clin North Am. 2017;64:677-684. [PMID: 28502445 DOI: 10.1016/j.pcl.2017.02.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
46 Hachem RR. The impact of non-HLA antibodies on outcomes after lung transplantation and implications for therapeutic approaches. Hum Immunol 2019;80:583-7. [PMID: 31005400 DOI: 10.1016/j.humimm.2019.04.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
47 Haugen CE, Thomas AG, Garonzik-Wang J, Massie AB, Segev DL. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study. Transplantation 2018;102:1514-9. [PMID: 29570165 DOI: 10.1097/TP.0000000000002190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
48 Emamaullee JA, Nekrasov V, Gilmour S, Kneteman N, Yanni G, Kohli R, Thomas D, Genyk Y. Case series and systematic review of acquired diaphragmatic hernia after liver transplantation. Pediatr Transplant 2018;22:e13296. [PMID: 30280450 DOI: 10.1111/petr.13296] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
49 Venick RS, Farmer DG, Soto JR, Vargas J, Yersiz H, Kaldas FM, Agopian VG, Hiatt JR, Mcdiarmid SV, Busuttil RW. One Thousand Pediatric Liver Transplants During Thirty Years: Lessons Learned. Journal of the American College of Surgeons 2018;226:355-66. [DOI: 10.1016/j.jamcollsurg.2017.12.042] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 9.5] [Reference Citation Analysis]
50 Samoylova ML, Nigrini MJ, Dodge JL, Roberts JP. Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list. Hepatology 2017;66:1144-50. [PMID: 28520210 DOI: 10.1002/hep.29269] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
51 Martin MT, Koppe S. Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis. Transplantation 2017;101:2088-91. [PMID: 28376038 DOI: 10.1097/TP.0000000000001758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Gao Q, Mulvihill MS, Scheuermann U, Davis RP, Yerxa J, Yerokun BA, Hartwig MG, Sudan DL, Knechtle SJ, Barbas AS. Improvement in Liver Transplant Outcomes From Older Donors: A US National Analysis. Ann Surg. 2018;. [PMID: 29958229 DOI: 10.1097/SLA.0000000000002876] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
53 Wey A, Gustafson SK, Salkowski N, Kasiske BL, Skeans M, Schaffhausen CR, Israni AK, Snyder JJ. Association of pretransplant and posttransplant program ratings with candidate mortality after listing. Am J Transplant 2019;19:399-406. [PMID: 30040191 DOI: 10.1111/ajt.15032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
54 Lee WC, Wang YC, Hsu HY, Hsu PY, Cheng CH, Lee CF, Wu TJ, Chan KM. Immunological discrepancy in aged mice facilitates skin allograft survival. Aging (Albany NY) 2021;13:16219-28. [PMID: 34157682 DOI: 10.18632/aging.203152] [Reference Citation Analysis]
55 Mazariegos GV. Critical elements in pediatric allograft selection. Liver Transpl 2017;23:S56-8. [PMID: 28719133 DOI: 10.1002/lt.24818] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
56 Wong LL, Truong HP, Seto T, Lacar L, Naugler WE. Marked Decrease in Urgent Listing for Liver Transplantation Over Time: Evolution of Characteristics and Outcomes of Status-1 Liver Transplantation. Transplantation. 2018;102:e18-e25. [PMID: 28968354 DOI: 10.1097/tp.0000000000001967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Mogul DB, Luo X, Garonzik-Wang J, Bowring MG, Massie AB, Schwarz KB, Cameron AM, Bridges JFP, Segev DL. Expansion of the Liver Donor Supply Through Greater Use of Split-Liver Transplantation: Identifying Optimal Recipients. Liver Transpl 2019;25:119-27. [PMID: 30230191 DOI: 10.1002/lt.25340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
58 Kamal L, Yu JW, Reichman TW, Kang L, Bandyopadhyay D, Kumar D, King A, Gautam U, Bhati C, Yakubu I, Lacy K, Levy M, Gupta G. Impact of Induction Immunosuppression Strategies in Simultaneous Liver/Kidney Transplantation. Transplantation 2020;104:395-403. [PMID: 31022149 DOI: 10.1097/TP.0000000000002768] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Russell JO, Lu WY, Okabe H, Abrams M, Oertel M, Poddar M, Singh S, Forbes SJ, Monga SP. Hepatocyte-Specific β-Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes. Hepatology 2019;69:742-59. [PMID: 30215850 DOI: 10.1002/hep.30270] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 17.0] [Reference Citation Analysis]
60 Kollmann D, Sapisochin G, Goldaracena N, Hansen BE, Rajakumar R, Selzner N, Bhat M, McCluskey S, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M. Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation. Liver Transpl 2018;24:779-89. [PMID: 29604237 DOI: 10.1002/lt.25068] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
61 Nostedt JJ, Skubleny DT, Shapiro AMJ, Campbell S, Freed DH, Bigam DL. Normothermic Ex Vivo Machine Perfusion for Liver Grafts Recovered from Donors after Circulatory Death: A Systematic Review and Meta-Analysis. HPB Surg. 2018;2018:6867986. [PMID: 29849531 DOI: 10.1155/2018/6867986] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
62 Erro R, Bacchin R, Magrinelli F, Tomei P, Geroin C, Squintani G, Lupo A, Zaza G, Tinazzi M. Tremor induced by Calcineurin inhibitor immunosuppression: a single-centre observational study in kidney transplanted patients. J Neurol 2018;265:1676-83. [PMID: 29777361 DOI: 10.1007/s00415-018-8904-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Bral M, Gala-Lopez B, Bigam DL, Freed DH, Shapiro AMJ. Ex situ liver perfusion: Organ preservation into the future. Transplant Rev (Orlando) 2018;32:132-41. [PMID: 29691119 DOI: 10.1016/j.trre.2018.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Iesari S, Ackenine K, Foguenne M, De Reyck C, Komuta M, Bonaccorsi Riani E, Ciccarelli O, Coubeau L, Lai Q, Gianello P, Lerut J. Tacrolimus and Single Intraoperative High-dose of Anti-T-lymphocyte Globulins Versus Tacrolimus Monotherapy in Adult Liver Transplantation: One-year Results of an Investigator-driven Randomized Controlled Trial. Annals of Surgery 2018;268:776-83. [DOI: 10.1097/sla.0000000000002943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
65 Narvaez JRF, Nie J, Noyes K, Kayler LK. Transplant Outcomes of Donation After Circulatory Death Livers Recovered With Versus Without Premortem Heparin Administration. Liver Transpl 2019;26:247-55. [DOI: 10.1002/lt.25685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
66 Angelico R, Trapani S, Spada M, Colledan M, Ville de Goyet J, Salizzoni M, De Carlis L, Andorno E, Gruttadauria S, Ettorre GM, Cescon M, Rossi G, Risaliti A, Tisone G, Tedeschi U, Vivarelli M, Agnes S, De Simone P, Lupo LG, Di Benedetto F, Santaniello W, Zamboni F, Mazzaferro V, Rossi M, Puoti F, Camagni S, Grimaldi C, Gringeri E, Rizzato L, Nanni Costa A, Cillo U. A national mandatory‐split liver policy: A report from the Italian experience. Am J Transplant 2019. [DOI: 10.1111/ajt.15300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Gorgen A, Muaddi H, Zhang W, McGilvray I, Gallinger S, Sapisochin G. The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases. Can J Gastroenterol Hepatol. 2018;2018:9531925. [PMID: 29623268 DOI: 10.1155/2018/9531925] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
68 Azoulay D, Disabato M, Gomez-Gavara C, Feray C, Salloum C, Ngonggang N, Winter A, Hentati H, Levesque E, Lim C, Compagnon P. Liver Transplantation with "Hors Tour" Allocated Versus Standard MELD Allocated Grafts: Single-Center Audit and Impact on the Liver Pool in France. World J Surg 2020;44:912-24. [PMID: 31832704 DOI: 10.1007/s00268-019-05271-w] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
69 Ayloo S, Pentakota SR, Molinari M. Trends of characteristics and outcomes of donors and recipients of deceased donor liver transplantation in the United States: 1990 to 2013. World J Transplantation 2018; 8(5): 167-177 [PMID: 30211025 DOI: 10.5500/wjt.v8.i5.167] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
70 Hirode G, Saab S, Wong RJ. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw Open 2020;3:e201997. [PMID: 32239220 DOI: 10.1001/jamanetworkopen.2020.1997] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
71 Crismale JF, Ahmad J. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation. World J Gastroenterol 2019; 25(47): 6799-6812 [PMID: 31885421 DOI: 10.3748/wjg.v25.i47.6799] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
72 Bosley J, Boren C, Lee S, Grøtli M, Nielsen J, Uhlen M, Boren J, Mardinoglu A. Improving the economics of NASH/NAFLD treatment through the use of systems biology. Drug Discovery Today 2017;22:1532-8. [DOI: 10.1016/j.drudis.2017.07.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
73 Pradère P, Tudorache I, Magnusson J, Savale L, Brugiere O, Douvry B, Reynaud-Gaubert M, Claustre J, Borgne AL, Holm AM, Schultz HH, Knoop C, Godinas L, Fisher AJ, Hirschi S, Gottlieb J, Le Pavec J; Working Group on Heart/Lung Transplantation in Systemic Sclerosis. Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study. J Heart Lung Transplant 2018;37:903-11. [PMID: 29628135 DOI: 10.1016/j.healun.2018.03.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
74 Lichvar A, Tremblay S, Naik D, Lipscomb J, King E, Vinks AA, Christians U, Alloway RR. Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients. Pharmacotherapy 2019;39:564-75. [PMID: 30892704 DOI: 10.1002/phar.2260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
75 Fleming JN, Lai JC, Te HS, Said A, Spengler EK, Rogal SS. Opioid and opioid substitution therapy in liver transplant candidates: A survey of center policies and practices. Clin Transplant. 2017;31. [PMID: 28941292 DOI: 10.1111/ctr.13119] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
76 Flores A, Asrani SK. The donor risk index: A decade of experience. Liver Transpl 2017;23:1216-25. [DOI: 10.1002/lt.24799] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
77 Mckiernan PJ, Ganoza A, Squires JE, Squires RH, Vockley J, Mazariegos G, Soltys K, Sun Q, Sindhi R. Evolving Trends in Liver Transplant for Metabolic Liver Disease in the United States. Liver Transpl 2019;25:911-21. [DOI: 10.1002/lt.25433] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
78 Gorgen A, Rosales R, Sadler E, Beecroft R, Knox J, Dawson LA, Ghanekar A, Grant D, Greig PD, Sapisochin G. Patterns and Predictors of Mortality After Waitlist Dropout of Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation. Transplantation 2019;103:2136-43. [DOI: 10.1097/tp.0000000000002616] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Woodrell CD, Hansen L, Schiano TD, Goldstein NE. Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults. Clin Ther 2018;40:512-25. [PMID: 29571567 DOI: 10.1016/j.clinthera.2018.02.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
80 Patel A, Asch S, Antonio AL, Kanwal F, Lorenz K, Riopelle D, Dickey A, Larkin J, Lee M, Walling A. Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease. Dig Dis Sci 2020;65:2562-70. [PMID: 31927765 DOI: 10.1007/s10620-019-05983-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 Yu YD, Hwang R, Halazun KJ, Griesemer A, Kato T, Emond J, Samstein B. Whose Liver Is It Anyway? Two Centers Participating in One Living Donor Transplantation. Liver Transpl 2019;25:1710-3. [PMID: 31273912 DOI: 10.1002/lt.25596] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Saliba F, Fischer L, de Simone P, Bernhardt P, Bader G, Fung J. Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression. Ann Transplant 2018;23:751-7. [PMID: 30361470 DOI: 10.12659/AOT.911030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
83 Saracino RM, Jutagir DR, Cunningham A, Foran-Tuller KA, Driscoll MA, Sledge WH, Emre SH, Fehon DC. Psychiatric Comorbidity, Health-Related Quality of Life, and Mental Health Service Utilization Among Patients Awaiting Liver Transplant. J Pain Symptom Manage 2018;56:44-52. [PMID: 29526612 DOI: 10.1016/j.jpainsymman.2018.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
84 Mainardi V, Rando K, Olivari D, Rey G, Castelli J, Grecco G, Leites A, Harguindeguy M, Gerona S. Mortality Analysis of Acute Liver Failure in Uruguay. Transplant Proc 2018;50:465-71. [PMID: 29579829 DOI: 10.1016/j.transproceed.2017.12.037] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Chagas AL, Mattos AA, Diniz MA, Felga GEG, Boin IFSF, Silva RCMA, Silva RF, Garcia JHP, Lima AS, Coelho JCU, Bittencourt PL, Alves VAF, D'Albuquerque LAC, Carrilho FJ; Brazilian HCC Study Group. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study. Ann Hepatol 2021;22:100294. [PMID: 33276136 DOI: 10.1016/j.aohep.2020.100294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Bhatt H, Rao GS. Management of Acute Liver Failure: A Pediatric Perspective. Curr Pediatr Rep 2018;6:246-57. [PMID: 32288972 DOI: 10.1007/s40124-018-0174-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Oliva J. Proteasome and Organs Ischemia-Reperfusion Injury. Int J Mol Sci 2017;19:E106. [PMID: 29301204 DOI: 10.3390/ijms19010106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
88 Siddique O, Siddique AS, Machan JT, Promrat K. Effects of infection on post-transplant outcomes: living versus deceased donor liver transplants. Clin Exp Hepatol 2018;4:28-34. [PMID: 29594195 DOI: 10.5114/ceh.2018.73464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Munshi VN, Saghafian S, Cook CB, Werner KT, Chakkera HA. Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients. PLoS One 2020;15:e0226873. [PMID: 31923179 DOI: 10.1371/journal.pone.0226873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
90 Hoppmann N, Massoud O. Medical care of liver transplant patients. Expert Rev Gastroenterol Hepatol 2020;14:901-18. [PMID: 32684007 DOI: 10.1080/17474124.2020.1797483] [Reference Citation Analysis]
91 Cui B, Lin L, Wang B, Liu W, Sun C. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer? Pharmacol Res 2021;175:106022. [PMID: 34883213 DOI: 10.1016/j.phrs.2021.106022] [Reference Citation Analysis]
92 Lange NW, Salerno DM, Sammons CM, Jesudian AB, Verna EC, Brown RS. Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction. Clin Transplant 2018;32:e13415. [DOI: 10.1111/ctr.13415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
93 Nagai S, Safwan M, Collins K, Schilke RE, Rizzari M, Moonka D, Brown K, Patel A, Yoshida A, Abouljoud M. Liver alone or simultaneous liver-kidney transplant? Pretransplant chronic kidney disease and post-transplant outcome - a retrospective study. Transpl Int 2018;31:1028-40. [DOI: 10.1111/tri.13275] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
94 Fleming JN, Taber DJ, Pilch NA, Mardis CR, Gilbert RE, Wilson LZ, Patel N, Ball S, Mauldin P, Baliga PK. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. Journal of the American College of Surgeons 2018;226:651-9. [DOI: 10.1016/j.jamcollsurg.2017.12.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
95 Strohbehn GW, Pan WW, Petrilli CM, Heidemann L, Larson S, Aaronson KD, Johnson M, Ellies T, Heung M. Large-Scale Variability of Inpatient Tacrolimus Therapeutic Drug Monitoring at an Academic Transplant Center: A Retrospective Study. Therapeutic Drug Monitoring 2018;40:394-400. [DOI: 10.1097/ftd.0000000000000526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
96 Kalra A, Biggins SW. New paradigms for organ allocation and distribution in liver transplantation. Current Opinion in Gastroenterology 2018;34:123-31. [DOI: 10.1097/mog.0000000000000434] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
97 Garrison KL, German P, Mogalian E, Mathias A. The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection. Drug Metab Dispos. 2018;46:1212-1225. [PMID: 29695614 DOI: 10.1124/dmd.117.079038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
98 Tsai K, Li L, Hsu C, Lin C, Lin Y, Cheng Y, Wang C, Chen C. Effects of Conversion From Calcineurin Inhibitors to Sirolimus or Everolimus on Renal Function and Possible Mechanisms in Liver Transplant Recipients. The Journal of Clinical Pharmacology 2019;59:326-34. [DOI: 10.1002/jcph.1334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Asrani SK, Hall L, Hagan M, Sharma S, Yeramaneni S, Trotter J, Talwalkar J, Kanwal F. Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study. Am J Gastroenterol 2019;114:98-106. [PMID: 30333543 DOI: 10.1038/s41395-018-0365-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
100 Luo S, Xiao S, Ai Y, Wang B, Wang Y. Changes in the hepatic differentiation potential of human mesenchymal stem cells aged in vitro. Ann Transl Med 2021;9:1628. [PMID: 34926672 DOI: 10.21037/atm-21-4918] [Reference Citation Analysis]
101 Liu X, Shin HP, Yoo JW. More Sensitivity Analysis of Share 35, Human Immunodeficiency Virus Co-infection, Delist, Hospital Cost on Cost Effectiveness of Direct-Acting Antiviral Agents for Liver Transplant Hepatitis C Virus Patients. Clin Gastroenterol Hepatol 2017;15:1979-81. [PMID: 28826914 DOI: 10.1016/j.cgh.2017.07.043] [Reference Citation Analysis]
102 Kim MH, Akbari O, Genyk Y, Kohli R, Emamaullee J. Immunologic benefit of maternal donors in pediatric living donor liver transplantation. Pediatr Transplant 2019;23:e13560. [PMID: 31402535 DOI: 10.1111/petr.13560] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
103 Sharma P, Goodrich NP, Schaubel DE, Smith AR, Merion RM. National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival. Liver Transpl 2017;23:1143-52. [PMID: 28688150 DOI: 10.1002/lt.24813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 DiLoreto R, Khush K, De Vlaminck I. Precision monitoring of immunotherapies in solid organ and hematopoietic stem cell transplantation. Adv Drug Deliv Rev 2017;114:272-84. [PMID: 28625828 DOI: 10.1016/j.addr.2017.06.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
105 Bababekov YJ, Hung YC, Chang DC, Rickert CG, Adler JT, Bethea E, Pomfret EA, Pomposelli JJ, Yeh H. Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease? Transplantation 2020;104:280-4. [PMID: 31335769 DOI: 10.1097/TP.0000000000002858] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
106 Raices M, Czerwonko ME, Ardiles V, Boldrini G, D'Agostino D, Marcó Del Pont J, Pekolj J, Mattera J, Brandi C, Ciardullo M, de Santibañes E, de Santibañes M. Short- and Long-Term Outcomes After Live-Donor Transplantation with Hyper-Reduced Liver Grafts in Low-Weight Pediatric Recipients. J Gastrointest Surg 2019;23:2411-20. [PMID: 30887299 DOI: 10.1007/s11605-019-04188-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
107 Yang JD, Mannalithara A, Piscitello AJ, Kisiel JB, Gores GJ, Roberts LR, Kim WR. Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis. Hepatology 2018;68:78-88. [PMID: 29023828 DOI: 10.1002/hep.29594] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
108 Moon AM, Green PK, Rockey DC, Berry K, Ioannou GN. Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding. Aliment Pharmacol Ther 2020;51:364-73. [PMID: 31773763 DOI: 10.1111/apt.15586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
109 Luo S, Ai Y, Xiao S, Wang B, Wang Y. Functional hit 1 (FH1)-based rapid and efficient generation of functional hepatocytes from human mesenchymal stem cells: a novel strategy for hepatic differentiation. Ann Transl Med 2021;9:1087. [PMID: 34422999 DOI: 10.21037/atm-21-2829] [Reference Citation Analysis]
110 Haugen CE, Holscher CM, Luo X, Bowring MG, Orandi BJ, Thomas AG, Garonzik-Wang J, Massie AB, Philosophe B, McAdams-DeMarco M, Segev DL. Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016. JAMA Surg 2019;154:441-9. [PMID: 30758494 DOI: 10.1001/jamasurg.2018.5568] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
111 Shoreibah M, Romano J, Sims OT, Guo Y, Jones D, Venkata K, Kommineni V, Orr J, Fitzmorris P, Massoud OI. Effect of Hepatitis C Treatment on Renal Function in Liver Transplant Patients. J Clin Transl Hepatol 2018;6:391-5. [PMID: 30637216 DOI: 10.14218/JCTH.2018.00026] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salamé E, Neau-Cransac M, Vanlemmens C, Durand F, Pageaux G, Leroy V, Hardwigsen J, Gharbi H, Masson C, Tindel M, Conti F. Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years. Liver Transpl 2019;25:1822-32. [PMID: 31631501 DOI: 10.1002/lt.25664] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
113 Yoeli D, Goss M, Galván NTN, Desai MS, Miloh TA, Rana A. Trends in pediatric liver transplant donors and deceased donor circumstance of death in the United States, 2002-2015. Pediatr Transplant 2018;22:e13156. [PMID: 29380468 DOI: 10.1111/petr.13156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
114 Wu Y, Huang M, Sun H, Zhou X, Zhou R, Gu G, Xia Q. Role of Innate Immunity in Pediatric Post-transplant Idiopathic Liver Fibrosis. Front Immunol 2020;11:2111. [PMID: 33193293 DOI: 10.3389/fimmu.2020.02111] [Reference Citation Analysis]
115 Barbaro RP, Xu Y, Borasino S, Truemper EJ, Watson RS, Thiagarajan RR, Wypij D, Curley MAQ; RESTORE Study Investigators *. Does Extracorporeal Membrane Oxygenation Improve Survival in Pediatric Acute Respiratory Failure? Am J Respir Crit Care Med 2018;197:1177-86. [PMID: 29373797 DOI: 10.1164/rccm.201709-1893OC] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
116 Jochmans I, Fieuws S, Tieken I, Samuel U, Pirenne J. The Impact of Hepatectomy Time of the Liver Graft on Post-transplant Outcome: A Eurotransplant Cohort Study. Ann Surg 2019;269:712-7. [PMID: 29166361 DOI: 10.1097/SLA.0000000000002593] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 8.5] [Reference Citation Analysis]
117 Gupta M, Gabriel H, Miller FH. Role of Imaging in Surveillance and Diagnosis of Hepatocellular Carcinoma. Gastroenterology Clinics of North America 2018;47:585-602. [DOI: 10.1016/j.gtc.2018.04.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
118 Getsuwan S, Chuthapisith J, Treepongkaruna S, Butsriphum N, Prabpram W, Charoenthanakit C, Tanpowpong P, Lertudomphonwanit C. Behavior Problems and Cognitive Function in Pediatric Liver Transplant Recipients. Transplant Proc 2021;53:649-55. [PMID: 33483167 DOI: 10.1016/j.transproceed.2020.10.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Park YS, Moon YJ, Jun IG, Song JG, Hwang GS. Application of the Revised Cardiac Risk Index to the Model for End-Stage Liver Disease Score Improves the Prediction of Cardiac Events in Patients Undergoing Liver Transplantation. Transplant Proc 2018;50:1108-13. [PMID: 29731076 DOI: 10.1016/j.transproceed.2018.01.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
120 Wey A, Gustafson SK, Salkowski N, Pyke J, Kasiske BL, Israni AK, Snyder JJ. Program-specific transplant rate ratios: Association with allocation priority at listing and posttransplant outcomes. Am J Transplant 2018;18:1360-9. [PMID: 29397038 DOI: 10.1111/ajt.14684] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
121 Getsuwan S, Tanpowpong P, Lertudomphonwanit C, Chuthapisith J, Butsriphum N, Prabpram W, Charoenmuang R, Treepongkaruna S. Health-Related Quality of Life in Pediatric Liver Transplant Recipients. Transplant Proc 2021;53:141-7. [PMID: 32417036 DOI: 10.1016/j.transproceed.2020.02.175] [Reference Citation Analysis]
122 Taylor R, Allen E, Richards JA, Goh MA, Neuberger J, Collett D, Pettigrew GJ. Survival advantage for patients accepting the offer of a circulatory death liver transplant. Journal of Hepatology 2019;70:855-65. [DOI: 10.1016/j.jhep.2018.12.033] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
123 Dheer D, Jyoti, Gupta PN, Shankar R. Tacrolimus: An updated review on delivering strategies for multifarious diseases. European Journal of Pharmaceutical Sciences 2018;114:217-27. [DOI: 10.1016/j.ejps.2017.12.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
124 Badawy A, Kaido T, Uemoto S. Current Status of Liver Transplantation Using Marginal Grafts. Journal of Investigative Surgery 2020;33:553-64. [DOI: 10.1080/08941939.2018.1517197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Sacco P, Sultan S, Tuten M, Powell JM, Connelly M, Barth RN, Hodorowicz M, LaMattina JC. Substance Use and Psychosocial Functioning in a Sample of Liver Transplant Recipients with Alcohol-Related Liver Disease. Transplant Proc 2018;50:3689-93. [PMID: 30577256 DOI: 10.1016/j.transproceed.2018.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
126 Jutagir DR, Saracino RM, Cunningham A, Foran-Tuller KA, Driscoll MA, Sledge WH, Emre SH, Fehon DC. The feasibility of a group stress management Liver SMART intervention for patients with end-stage liver disease: A pilot study. Palliat Support Care 2019;17:35-41. [PMID: 29860964 DOI: 10.1017/S147895151800024X] [Reference Citation Analysis]
127 Kwong AJ, Kim WR, Flemming JA. De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era. Hepatology. 2018;68:1288-1297. [PMID: 29672886 DOI: 10.1002/hep.30045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
128 Quadros J, Piedade C, Lopes MF. Auxiliary liver transplantation for management of acute liver failure in children - Systematic review. Transplant Rev (Orlando) 2021;35:100631. [PMID: 34098491 DOI: 10.1016/j.trre.2021.100631] [Reference Citation Analysis]
129 Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. Hepatology 2019;69:1193-205. [PMID: 30548884 DOI: 10.1002/hep.30413] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
130 Palladini G, Di Pasqua LG, Berardo C, Siciliano V, Richelmi P, Perlini S, Ferrigno A, Vairetti M. Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress. Can J Gastroenterol Hepatol 2019;2019:5413461. [PMID: 30854350 DOI: 10.1155/2019/5413461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
131 Perito ER, Roll G, Dodge JL, Rhee S, Roberts JP. Split Liver Transplantation and Pediatric Waitlist Mortality in the United States: Potential for Improvement. Transplantation 2019;103:552-7. [PMID: 29684000 DOI: 10.1097/TP.0000000000002249] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 9.3] [Reference Citation Analysis]
132 Takahashi K, Nagai S, Safwan M, Liang C, Ohkohchi N. Thrombocytopenia after liver transplantation: Should we care? World J Gastroenterol 2018; 24(13): 1386-1397 [PMID: 29632420 DOI: 10.3748/wjg.v24.i13.1386] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
133 Tchilikidi KY. Liver graft preservation methods during cold ischemia phase and normothermic machine perfusion. World J Gastrointest Surg 2019; 11(3): 126-142 [PMID: 31057698 DOI: 10.4240/wjgs.v11.i3.126] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
134 Quintini C, Martins PN, Shah S, Killackey M, Reed A, Guarrera J, Axelrod DA; for the American Society of Transplant Surgeons Standards Committee. Implementing an innovated preservation technology: The American Society of Transplant Surgeons’ (ASTS) Standards Committee White Paper on Ex Situ Liver Machine Perfusion. Am J Transplant 2018;18:1865-74. [DOI: 10.1111/ajt.14945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
135 Mazzaferro V, Battiston C, Sposito C. Pro (With Caution): Extended oncologic indications in liver transplantation: Mazzaferro et al. Liver Transpl 2018;24:98-103. [DOI: 10.1002/lt.24963] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
136 Ward A, Klassen DK, Franz KM, Giwa S, Lewis JK. Social, economic, and policy implications of organ preservation advances. Curr Opin Organ Transplant 2018;23:336-46. [PMID: 29683801 DOI: 10.1097/MOT.0000000000000532] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
137 Baganate F, Beal EW, Tumin D, Azoulay D, Mumtaz K, Black SM, Washburn K, Pawlik TM. Early mortality after liver transplantation: Defining the course and the cause. Surgery 2018;164:694-704. [DOI: 10.1016/j.surg.2018.04.039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
138 Kwong A, Kim WR, Mannalithara A, Heo NY, Udompap P, Kim D. Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States. Liver Transpl. 2018;24:735-743. [PMID: 29125676 DOI: 10.1002/lt.24973] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
139 Adam R, Karam V, Cailliez V, Trunečka P, Samuel D, Tisone G, Němec P, Soubrane O, Schneeberger S, Gridelli B, Bechstein WO, Risaliti A, Line PD, Vivarelli M, Rossi M, Pirenne J, Klempnauer JL, Rummo A, Di Benedetto F, Zieniewicz K, Troisi R, Paul A, Vali T, Kollmar O, Boudjema K, Hoti E, Colledan M, Pratschke J, Lang H, Popescu I, Ericzon BG, Strupas K, De Simone P, Kochs E, Heyd B, Gugenheim J, Pinna AD, Bennet W, Kazimi M, Bachellier P, Wigmore SJ, Rasmussen A, Clavien PA, Hidalgo E, O'Grady JG, Zamboni F, Kilic M, Duvoux C; all contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA). Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension Study. Transplantation 2019;103:1844-62. [PMID: 31343568 DOI: 10.1097/TP.0000000000002700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
140 Chhatwal J, Samur S, Bethea ED, Ayer T, Kanwal F, Hur C, Roberts MS, Terrault N, Chung RT. Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study. Hepatology. 2018;67:2085-2095. [PMID: 29222916 DOI: 10.1002/hep.29723] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 9.5] [Reference Citation Analysis]
141 Samstein B, de Melo-Martin I, Kapur S, Ratner L, Emond J. A liver for a kidney: Ethics of trans-organ paired exchange. Am J Transplant 2018;18:1077-82. [PMID: 29442420 DOI: 10.1111/ajt.14690] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
142 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182-236. [PMID: 29628281 DOI: 10.1016/j.jhep.2018.03.019] [Cited by in Crossref: 2122] [Cited by in F6Publishing: 1974] [Article Influence: 530.5] [Reference Citation Analysis]
143 Cañon Reyes I, Halac E, Aredes D, Lauferman L, Cervio G, Dip M, Minetto J, Reijenstein H, Meza V, Gole M, Jacobo Dillon A, Imventarza O. Prognostic Factors in Pediatric Early Liver Retransplantation. Liver Transpl 2020;26:528-36. [DOI: 10.1002/lt.25719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Lindenmeyer CC, Kim A, Sanghi V, Lopez R, Niyazi F, Mehta NA, Flocco G, Kapoor A, Carey WD, Romero-Marrero C. The EMALT Score: An Improved Model for Prediction of Early Mortality in Liver Transplant Recipients. J Intensive Care Med 2020;35:781-8. [PMID: 29996705 DOI: 10.1177/0885066618784869] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
145 Mundi MS, Velapati S, Patel J, Kellogg TA, Abu Dayyeh BK, Hurt RT. Evolution of NAFLD and Its Management. Nutr Clin Pract 2020;35:72-84. [PMID: 31840865 DOI: 10.1002/ncp.10449] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
146 Munshi VN, Saghafian S, Cook CB, Eric Steidley D, Hardaway B, Chakkera HA. Incidence, Risk Factors, and Trends for Postheart Transplantation Diabetes Mellitus. Am J Cardiol 2020;125:436-40. [PMID: 31812226 DOI: 10.1016/j.amjcard.2019.10.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
147 Wirth KM, Kizy S, Steer CJ. Liver Regeneration in the Acute Liver Failure Patient. Clin Liver Dis. 2018;22:269-287. [PMID: 29605066 DOI: 10.1016/j.cld.2018.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
148 Boylan JM, Francois-Vaughan H, Gruppuso PA, Sanders JA. Engraftment and Repopulation Potential of Late Gestation Fetal Rat Hepatocytes. Transplantation. 2017;101:2349-2359. [PMID: 28749819 DOI: 10.1097/tp.0000000000001882] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
149 Pezzati D, Hassan A, Buccini L, Liu Q, Diago Uso T, Quintini C. Liver transplantation with geriatric liver allograft in the US: a matter of epidemiology or outcome requirements? Transpl Int 2017;30:1190-1. [PMID: 28777472 DOI: 10.1111/tri.13013] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
150 Giard J, Dodge JL, Terrault NA. Superior Wait‐List Outcomes in Patients with Alcohol‐Associated Liver Disease Compared With Other Indications for Liver Transplantation. Liver Transpl 2019;25:1310-20. [DOI: 10.1002/lt.25485] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
151 Chen YM, Yu TW, Wang CC, Huang KT, Hsu LW, Lin CC, Liu YW, Li WF, Chen CL, Chen CC. Characteristics of Psychosocial Factors in Liver Transplantation Candidates with Alcoholic Liver Disease before Transplantation: A Retrospective Study in a Single Center in Taiwan. Int J Environ Res Public Health 2020;17:E8696. [PMID: 33238532 DOI: 10.3390/ijerph17228696] [Reference Citation Analysis]
152 Bethea ED, Samur S, Kanwal F, Ayer T, Hur C, Roberts MS, Terrault N, Chung RT, Chhatwal J. Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy. Clin Gastroenterol Hepatol. 2019;17:739-747.e8. [PMID: 30138735 DOI: 10.1016/j.cgh.2018.08.042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
153 Jayant K, Reccia I, Virdis F, Shapiro AMJ. The Role of Normothermic Perfusion in Liver Transplantation (TRaNsIT Study): A Systematic Review of Preliminary Studies. HPB Surg. 2018;2018:6360423. [PMID: 29887782 DOI: 10.1155/2018/6360423] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
154 Paterno F, Guarrera JV, Wima K, Diwan T, Cuffy MC, Anwar N, Woodle ES, Shah S. Clinical Implications of Donor Warm and Cold Ischemia Time in Donor After Circulatory Death Liver Transplantation. Liver Transpl 2019;25:1342-52. [DOI: 10.1002/lt.25453] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
155 Gastaca M, Ruiz P, Bustamante J, Martinez-Indart L, Ventoso A, Fernandez JR, Palomares I, Prieto M, Testillano M, Salvador P, Senosiain M, Suárez MJ, Valdivieso A. Early tacrolimus exposure does not impact long-term outcomes after liver transplantation. World J Hepatol 2021; 13(3): 362-374 [PMID: 33815678 DOI: 10.4254/wjh.v13.i3.362] [Reference Citation Analysis]
156 Li M, Chu Z, Tan Z, Jin Y, Xu M, Ji Q. Impact of donor age on liver regeneration and function following adult living donor liver transplantation. Exp Ther Med 2019;17:3965-70. [PMID: 31007739 DOI: 10.3892/etm.2019.7454] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Wedd J, Basu M, Curtis LM, Smith K, Lo DJ, Serper M, Wolf MS, Parker R, Patzer RE. Racial, Ethnic, and Socioeconomic Disparities in Web-Based Patient Portal Usage Among Kidney and Liver Transplant Recipients: Cross-Sectional Study. J Med Internet Res 2019;21:e11864. [PMID: 31008707 DOI: 10.2196/11864] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
158 Payancé A, Silva‐junior G, Bissonnette J, Tanguy M, Pasquet B, Levi C, Roux O, Nekachtali O, Baiges A, Hernández‐gea V, Laouénan C, Lebrec D, Albuquerque M, Paradis V, Moreau R, Valla D, Durand F, Boulanger CM, Garcia‐pagan J, Rautou P. Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis. Hepatology 2018;68:1508-18. [DOI: 10.1002/hep.29903] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
159 Forde KA, Fallon MB, Krowka MJ, Sprys M, Goldberg DS, Krok KL, Patel M, Lin G, Oh JK, Mottram CD, Scanlon PD, Kawut SM; Pulmonary Vascular Complications of Liver Disease 2 Study Group. Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation. Hepatology 2019;69:270-81. [PMID: 30070715 DOI: 10.1002/hep.30139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
160 Wey A, Salkowski N, Kasiske BL, Skeans M, Schaffhausen CR, Gustafson SK, Israni AK, Snyder JJ. Comparing Scientific Registry of Transplant Recipients posttransplant program-specific outcome ratings at listing with subsequent recipient outcomes after transplant. Am J Transplant 2019;19:391-8. [PMID: 30053337 DOI: 10.1111/ajt.15038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
161 Cheung A, Levitsky J. Follow-up of the Post-Liver Transplantation Patient: A Primer for the Practicing Gastroenterologist. Clin Liver Dis. 2017;21:793-813. [PMID: 28987263 DOI: 10.1016/j.cld.2017.06.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
162 Xu Q, Mcalister VC, Leckie S, House AA, Skaro A, Marotta P. Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation. Am J Transplant 2019;20:282-8. [DOI: 10.1111/ajt.15571] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
163 Ferrarese A, Zanetto A, Becchetti C, Sciarrone SS, Shalaby S, Germani G, Gambato M, Russo FP, Burra P, Senzolo M. Management of bacterial infection in the liver transplant candidate. World J Hepatol 2018; 10(2): 222-230 [PMID: 29527258 DOI: 10.4254/wjh.v10.i2.222] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
164 Londoño MC, Forns X, Pascasio JM. Reply to: "Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations". J Hepatol 2018;68:627-8. [PMID: 29080809 DOI: 10.1016/j.jhep.2017.10.009] [Reference Citation Analysis]
165 Haugen CE, Bowring MG, Holscher CM, Jackson KR, Garonzik-Wang J, Cameron AM, Philosophe B, McAdams-DeMarco M, Segev DL. Survival benefit of accepting livers from deceased donors over 70 years old. Am J Transplant 2019;19:2020-8. [PMID: 30614634 DOI: 10.1111/ajt.15250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
166 Kim YY, Kim M, Jeong E, Lee J. Organ donation from brain‐dead pediatric donors in Korea: A 5‐year data analysis (2013‐2017). Pediatr Transplant 2020;24. [DOI: 10.1111/petr.13686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
167 Saberi B, Hamilton JP, Durand CM, Li Z, Philosophe B, Cameron AM, Sulkowski MS, Gurakar A. Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient. Liver Transpl. 2018;24:140-143. [PMID: 28779557 DOI: 10.1002/lt.24838] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
168 Moris D, Shaw BI, Gloria J, Kesseli SJ, Samoylova ML, Schmitz R, Manook M, McElroy LM, Patel Y, Berg CL, Knechtle SJ, Sudan DL, Barbas AS. Textbook Outcomes in Liver Transplantation. World J Surg. 2020;44:3470-3477. [PMID: 32488663 DOI: 10.1007/s00268-020-05625-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
169 Watson CJE, Jochmans I. From "Gut Feeling" to Objectivity: Machine Preservation of the Liver as a Tool to Assess Organ Viability. Curr Transplant Rep 2018;5:72-81. [PMID: 29564205 DOI: 10.1007/s40472-018-0178-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 13.0] [Reference Citation Analysis]
170 Ochi T, Nakamura H, Wada M, Tamura T, Koga H, Okazaki T, Urao M, Ishizaki Y, Kawasaki S, Kasahara M, Mizuta K, Lane GJ, Yamataka A. Liver transplantation for deterioration in native liver function after portoenterostomy for biliary atresia in Japan: Short- versus long-term survivors. Journal of Pediatric Surgery 2018;53:277-80. [DOI: 10.1016/j.jpedsurg.2017.11.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
171 Singer JP, Diamond JM, Anderson MR, Katz PP, Covinsky K, Oyster M, Blue T, Soong A, Kalman L, Shrestha P, Arcasoy SM, Greenland JR, Shah L, Kukreja J, Blumenthal NP, Easthausen I, Golden JA, McBurnie A, Cantu E, Sonett J, Hays S, Robbins H, Raza K, Bacchetta M, Shah RJ, D'Ovidio F, Venado A, Christie JD, Lederer DJ. Frailty phenotypes and mortality after lung transplantation: A prospective cohort study. Am J Transplant 2018;18:1995-2004. [PMID: 29667786 DOI: 10.1111/ajt.14873] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
172 Kapila N, Khalloufi KA, Flocco G, Menon KVN, Lindenmeyer C, Reino D, Vanatta JM, Ebaid S, Tzakis A, Zervos XB. Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy. J Clin Transl Hepatol 2019;7:122-6. [PMID: 31293911 DOI: 10.14218/JCTH.2019.00014] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
173 Lim J, Curry MP, Sundaram V. Risk factors and outcomes associated with alcohol relapse after liver transplantation. World J Hepatol 2017; 9(17): 771-780 [PMID: 28660011 DOI: 10.4254/wjh.v9.i17.771] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
174 Hachem RR. The role of the immune system in lung transplantation: towards improved long-term results. J Thorac Dis. 2019;11:S1721-S1731. [PMID: 31632749 DOI: 10.21037/jtd.2019.04.25] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
175 Ohashi K, Pimienta M, Seki E. Alcoholic liver disease: A current molecular and clinical perspective. Liver Res. 2018;2:161-172. [PMID: 31214376 DOI: 10.1016/j.livres.2018.11.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
176 Sellers CM, Nezami N, Schilsky ML, Kim HS. Transjugular intrahepatic portosystemic shunt as a bridge to liver transplant: Current state and future directions. Transplant Rev (Orlando) 2019;33:64-71. [PMID: 30477811 DOI: 10.1016/j.trre.2018.10.004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
177 Tan PS, Muthiah MD, Koh T, Teoh YL, Chan A, Kow A, Zheng Q, Kwon CHD, Lee GH, Lesmana CRA, de Villa V, Fung J, Lim K. Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver Transplantation. Transplantation 2019;103:470-80. [DOI: 10.1097/tp.0000000000002532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
178 Danoy M, Bernier ML, Kimura K, Poulain S, Kato S, Mori D, Kido T, Plessy C, Kusuhara H, Miyajima A, Sakai Y, Leclerc E. Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment. Biotechnology and Bioengineering 2019;116:1762-76. [DOI: 10.1002/bit.26970] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
179 Rashidi-Alavijeh J, Straub K, Achterfeld A, Wedemeyer H, Willuweit K, Herzer K. Safety and efficacy of tenofovir alafenamide in liver transplant recipients: A single center experience. Transpl Infect Dis 2021;23:e13522. [PMID: 33217163 DOI: 10.1111/tid.13522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
180 Lee BP, Terrault NA. Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus. Curr Opin Organ Transplant 2018;23:229-36. [PMID: 29389821 DOI: 10.1097/MOT.0000000000000507] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 5.3] [Reference Citation Analysis]
181 Roccaro GA, Mitrani R, Hwang WT, Forde KA, Reddy KR. Sustained Virological Response Is Associated with a Decreased Risk of Posttransplant Diabetes Mellitus in Liver Transplant Recipients with Hepatitis C-Related Liver Disease. Liver Transpl 2018;24:1665-72. [PMID: 30291672 DOI: 10.1002/lt.25351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
182 Lim N, Singh D, Jackson S, Lake JR. Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus (HCV) Liver Transplant Recipients Treated with Pretransplant Direct-Acting Antiviral (DAA) Therapy. Gastrointest Tumors 2020;7:134-43. [PMID: 33173777 DOI: 10.1159/000510341] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
183 Marcellin P, Kutala BK. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 2018;38 Suppl 1:2-6. [PMID: 29427496 DOI: 10.1111/liv.13682] [Cited by in Crossref: 161] [Cited by in F6Publishing: 144] [Article Influence: 53.7] [Reference Citation Analysis]
184 George LA, Lominadze Z, Kallwitz ER. Transplantation: Loyola university (Con) patient and graft survival outcome at 1 and 3 years posttransplant do not reflect the value of successful liver transplantation. Clin Liver Dis (Hoboken) 2018;11:62-5. [PMID: 30992790 DOI: 10.1002/cld.670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 Goss MB, Rana A. ABO-incompatible liver transplantation: Is it a viable option with modern innovation? Clin Liver Dis (Hoboken). 2017;10:124-129. [PMID: 30992771 DOI: 10.1002/cld.673] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
186 McIntosh CM, Chen L, Shaiber A, Eren AM, Alegre ML. Gut microbes contribute to variation in solid organ transplant outcomes in mice. Microbiome 2018;6:96. [PMID: 29793539 DOI: 10.1186/s40168-018-0474-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
187 Navin PJ, Venkatesh SK. Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances. J Clin Transl Hepatol 2019;7:72-85. [PMID: 30944823 DOI: 10.14218/JCTH.2018.00032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
188 Jiang DD, Roayaie K, Woodland D, Orloff S, Scott D. Survival and renal function after liver transplantation alone in patients meeting the new United Network for Organ Sharing simultaneous liver‐kidney criteria. Clin Transplant 2020;34. [DOI: 10.1111/ctr.14020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
189 Asrani SK, Saracino G, O'leary JG, Gonzales S, Kim PT, Mckenna GJ, Klintmalm G, Trotter J. Recipient characteristics and morbidity and mortality after liver transplantation. Journal of Hepatology 2018;69:43-50. [DOI: 10.1016/j.jhep.2018.02.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
190 Duncan SE, Arnon R, DiPietrantonio C, Ehrlich K, Knight CS, Chu J, Annunziato RA. Pediatric Liver Transplant Teams Coping With Patient Death. J Pediatr Gastroenterol Nutr 2018;67:169-72. [PMID: 29620594 DOI: 10.1097/MPG.0000000000001991] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
191 Mishra A, Lo A, Lee GS, Samstein B, Yoo PS, Levine MH, Goldberg DS, Shaked A, Olthoff KM, Abt PL. Liver paired exchange: Can the liver emulate the kidney? Liver Transpl 2018;24:677-86. [PMID: 29427562 DOI: 10.1002/lt.25030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
192 Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151-171. [PMID: 30266282 DOI: 10.1016/j.jhep.2018.09.014] [Cited by in Crossref: 615] [Cited by in F6Publishing: 559] [Article Influence: 153.8] [Reference Citation Analysis]
193 Bababekov YJ, Ven Fong Z, Chang DC, Simpson MA, Yeh H, Pomposelli JJ. Is liver transplant education patient-centered?: Letters From the Frontline. Liver Transpl 2017;23:1070-2. [DOI: 10.1002/lt.24801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
194 Horrow MM, Huynh ML, Callaghan MM, Rodgers SK. Complications after Liver Transplant Related to Preexisting Conditions: Diagnosis, Treatment, and Prevention. RadioGraphics 2020;40:895-909. [DOI: 10.1148/rg.2019190120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
195 Shin MH, Song GW, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Yun YI, Kim WJ, Kang WH, Kim SH, Jiang H, Lee S, Tak EY. Once-daily, prolonged-release tacrolimus vs twice-daily, immediate-release tacrolimus in de novo living-donor liver transplantation: A Phase 4, randomized, open-label, comparative, single-center study. Clin Transplant. 2018;32:e13376. [PMID: 30098071 DOI: 10.1111/ctr.13376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
196 Freischlag K, Ezekian B, Schroder PM, Mulvihill MS, Cox ML, Hartwig MG, Knechtle S. A Propensity-matched Survival Analysis: Do Simultaneous Liver-lung Transplant Recipients Need a Liver? Transplantation 2019;103:1675-82. [PMID: 30444805 DOI: 10.1097/TP.0000000000002529] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
197 Fleming JN, Taber DJ, McElligott J, McGillicuddy JW, Treiber F. Mobile Health in Solid Organ Transplant: The Time Is Now. Am J Transplant 2017;17:2263-76. [PMID: 28188681 DOI: 10.1111/ajt.14225] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 9.2] [Reference Citation Analysis]
198 Roccaro GA, Goldberg DS, Hwang WT, Judy R, Thomasson A, Kimmel SE, Forde KA, Lewis JD, Yang YX. Sustained Posttransplantation Diabetes Is Associated With Long-Term Major Cardiovascular Events Following Liver Transplantation. Am J Transplant 2018;18:207-15. [PMID: 28640504 DOI: 10.1111/ajt.14401] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]